Phathom Pharmaceuticals Announces Food and drug administration Acceptance for Submitting of Vonoprazan NDA for the Remedy of Erosive Esophagitis
Phathom Prescription drugsFLORHAM PARK, N.J., May 25, 2022 (Globe NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company centered...